Dermapharm Holding SE (DMP.DE)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Hans-Georg Feldmeier | CEO & Chairman of the Management Board | 1.08M | -- | -- |
Mr. Christof Dreibholz | CFO, Chief Compliance Officer & Member of Management Board | 665k | -- | 1968 |
Dr. Andreas Eberhorn | Chief Marketing Officer & Member of Management Board | 657k | -- | 1976 |
Ms. Britta Hamberger | Head of Investor Relations & Corporate Communications | -- | -- | -- |
Dermapharm Holding SE
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 3,610
Description
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Corporate Governance
Upcoming Events
May 15, 2025 at 6:30 AM UTC
Dermapharm Holding SE Earnings Date
June 27, 2025 at 12:00 AM UTC
Ex-Dividend Date
Recent Events
Recent Events Information Not Available